er (UFH) administreres under PCI i henhold til lokale retningslinier under hensyntagen til patientens potentielle risiko for blødninger, inklusive tiden fra den sidste fondaparinuxdosis (se pkt.
ris per local practice should be administered during PCI, taking into account the patient’ s potential risk of bleeding, including the time since the last dose of fondaparinux (see section 4.4).